Can you provide the last earnings date for AVANOS MEDICAL INC?
AVANOS MEDICAL INC (AVNS) last reported earnings on 2/24/2026.
AVANOS MEDICAL INC (AVNS) Earnings History & Surprises
NYSE:AVNS • US05350V1061
Current stock price
13.4 USD
+0.35 (+2.68%)
At close:
13.4 USD
0 (0%)
After Hours:
AVNS Earnings overview
Past quarterly earnings results for AVANOS MEDICAL INC (AVNS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.14
- Revenue Estimate
- 173.4M
Last Reported
Most Recent- Release Date
- Feb 24, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.29
- EPS Surprise
- 14.64%
- Revenue Surprise
- 1.52%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.29 | 0.25 | 14.64% | -30.95% | 180.9M | 178.19M | 1.52% | 0.72% |
| Q3 2025 | 0.22 | 0.12 | 79.74% | -38.89% | 177.8M | 167.79M | 5.97% | 4.34% |
| Q2 2025 | 0.17 | 0.15 | 11.11% | -41.38% | 175M | 168.81M | 3.67% | 1.92% |
| Q1 2025 | 0.26 | 0.18 | 41.61% | 36.84% | 167.5M | 164.99M | 1.52% | 0.84% |
| Q4 2024 | 0.42 | 0.41 | 2.94% | 31.25% | 179.6M | 180.8M | -0.66% | 3.64% |
| Q3 2024 | 0.36 | 0.36 | -0.30% | -14.29% | 170.4M | 178.84M | -4.72% | -0.53% |
| Q2 2024 | 0.29 | 0.29 | -0.94% | -21.62% | 171.7M | 174.08M | -1.37% | 1.36% |
| Q1 2024 | 0.19 | 0.22 | -13.23% | -29.63% | 166.1M | 166.16M | -0.04% | -13.35% |
| Q4 2023 | 0.32 | 0.37 | -14.44% | -46.67% | 173.3M | 173.84M | -0.31% | -20.32% |
| Q3 2023 | 0.42 | 0.29 | 47.06% | 10.53% | 171.3M | 172.99M | -0.98% | -0.58% |
| Q2 2023 | 0.37 | 0.30 | 21.73% | -9.76% | 169.4M | 189.95M | -10.82% | -0.88% |
| Q1 2023 | 0.27 | 0.28 | -3.48% | 3.85% | 191.7M | 199.1M | -3.72% | 20.34% |
| Q4 2022 | 0.60 | 0.50 | 20.05% | 30.43% | 217.5M | 221.65M | -1.87% | 12.46% |
| Q3 2022 | 0.38 | 0.36 | 5.69% | 52.00% | 172.3M | 209.58M | -17.79% | -6.41% |
| Q2 2022 | 0.41 | 0.39 | 5.23% | 95.24% | 170.9M | 212.44M | -19.55% | -8.32% |
| Q1 2022 | 0.26 | 0.27 | -1.96% | 13.04% | 159.3M | 201.76M | -21.04% | -11.84% |
| Q4 2021 | 0.46 | 0.41 | 12.18% | 64.29% | 193.4M | 195.15M | -0.90% | 4.54% |
| Q3 2021 | 0.25 | 0.31 | -18.75% | 19.05% | 184.1M | 189.05M | -2.62% | -0.86% |
| Q2 2021 | 0.21 | 0.24 | -11.76% | 61.54% | 186.4M | 184.17M | 1.21% | 13.87% |
| Q1 2021 | 0.23 | 0.19 | 21.89% | 43.75% | 180.7M | 178.95M | 0.98% | 0.17% |
| Q4 2020 | 0.28 | 0.22 | 26.69% | - | 185M | 187.83M | -1.51% | - |
| Q3 2020 | 0.21 | 0.10 | 105.88% | - | 185.7M | 169.18M | 9.76% | - |
| Q2 2020 | 0.13 | -0.10 | 227.45% | - | 163.7M | 150.86M | 8.51% | - |
| Q1 2020 | 0.16 | 0.16 | -0.40% | - | 180.4M | 178.72M | 0.94% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
36.78%
Max EPS beat (4)
79.74%
Min EPS beat (4)
11.11%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
3.17%
Max Revenue beat (4)
5.97%
Min Revenue beat (4)
1.52%
Analysis
In the last 4 quarters, AVNS has consistently beaten EPS estimates in all releases
AVNS has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, AVNS has beaten the EPS estimates by 36.8% on average.
In the last 4 quarters, AVNS has beaten the revenue estimates by 3.2% on average.
Related analysis
AVANOS MEDICAL INC / AVNS Earnings FAQ
Did AVNS stock beat earnings estimates in the most recent quarter?
AVANOS MEDICAL INC (AVNS) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often AVANOS MEDICAL INC beats earnings estimates?
In the last 4 quarters, AVANOS MEDICAL INC (AVNS) has beaten EPS estimates in 4 out of 4 releases.